Abstract
Purpose: The Brugada syndrome (BrS) is a severe inherited cardiac disorder. Given the high genetic and phenotypic heterogeneity of this disease, three different “omics” approaches are integrated in a synergic way to elucidate the molecular mechanisms underlying the pathophysiology of BrS as well as for identifying reliable diagnostic/prognostic markers. Experimental design: The profiling of plasma Proteome and MiRNome is perfomed in a cohort of Brugada patients that were preliminary subjected to genomic analysis to assess a peculiar gene mutation profile. Results: The integrated analysis of “omics” data unveiled a cooperative activity of mutated genes, deregulated miRNAs and proteins in orchestrating transcriptional and post-translational events that are critical determining factors for the development of the Brugada pattern. Conclusions and clinical relevance: This study provides the basis to shed light on the specific molecular fingerprints underlying BrS development and to gain further insights on the pathogenesis of this life-threatening cardiac disease.
Original language | English |
---|---|
Pages (from-to) | 1-15 |
Number of pages | 15 |
Journal | PROTEOMICS. CLINICAL APPLICATIONS |
Volume | 12 |
DOIs | |
Publication status | Published - 2018 |
Keywords
- Clinical Biochemistry
- MiRNA
- brugada syndrome
- genomics
- personalized medicine
- proteomics
- reactive oxygen species